Epidemiology and natural history of hepatitis B

Seminars in Liver Disease

Volumn 25, Issue SUPPL. 1, 2005, Pages 3-8

  McMahon, Brian J ^a,b  

^a ALASKA NATIVE MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Hepatitis B virus; Management; Natural history

Indexed keywords

ANTIVIRUS AGENT; LAMIVUDINE;

CHRONIC DISEASE; DEMOGRAPHY; DISEASE MARKER; DISEASE SEVERITY; ENDEMIC DISEASE; ENVIRONMENTAL FACTOR; FOLLOW UP; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; IMMIGRANT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SOCIAL ASPECT; VIRUS MUTATION;

CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; PREVALENCE; RISK FACTORS;

EID: 24344435917     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-915644     Document Type: Review

References (25)

1. Lee W. Hepatitis B virus infection. N Engl J Med 1997;337: 1733-1745
2. Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-1956
3. McMahon BJ. Hepatocellular carcinoma and viral hepatitis. In: Wilson RA, ed. Viral Hepatitis. New York: Marcel Dekker; 1997:315-330
4. McMahon BJ, Holck P, Bulkow L, Snowball MM. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 2001;135: 759-768
5. McQuillan GM, Townsend TR, Fields HA, Carrol M, Leahy M, Polk BF. Seroepidemiology of hepatitis B virus infection in the United States. Am J Med 1989;87(suppl 3A):5S-10S
6. CDC. Hepatitis B virus: a comprehensive strategy for limiting transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991;40:RR-13:1-25
7. Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;322:1099-1102
8. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week [letter]. Lancet 1981;1:550-551
9. Petersen NJ, Barrett DH, Bond WW, et al. Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl Environ Microbiol 1976;32:572-574
10. Beasley RP, Hwang LY, Lin CC, et al. Incidence of hepatitis B virus in preschool children in Taiwan. J Infect Dis 1982; 146:198-204
11. Corsaget P, Yvonnet B, Chotard J, et al. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol 1987;22:1-5
12. McMahon BJ, Alward WLM, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985;151:599-603
13. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B 2000. Summary of a workshop. Gastroenterology 2001;120:1828-1853
14. McMahon BJ. Chronic carriers of hepatitis B virus who clear hepatitis B surface antigen: Are they really "off the hook"? Hepatology 1998;28:265-267
15. Wai CT, Fontana RJ. Clinical significance of hepatitis B virus genotypes, variants, and mutants. Clin Liver Dis 2004;8:321-352
16. Lok ASF, McMahon BJ. American Association for the Study of Liver Disease Practice Guideline: chronic hepatitis B. Hepatology 2001;34:1225-1241
17. Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 2003;46:329-338
18. Chu CJ, Keeffe EB, Han SH, et al. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 2003;125:444-451
19. Kao JH, Chen PJ, Lai MY, Chen DS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003;124:327-334
20. Chu CJ, Keeffe EB, Han SY, et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 2003;38:619-628
21. Hadziyannis SJ. Hepatitis D. Clin Liver Dis 1999;3:309-325
22. Liaw YF, Sung JJY, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004;351:1521-1531
23. Yang B, Zhang B, Xu Y, et al. Prospective study of early detection for primary liver cancer. J Cancer Res Clin Oncol 1997;123:357-360
24. The EASL Jury EASL International Consensus Conference on Hepatitis B 13-14 September, 2002, Geneva, Switzerland. Consensus statement (short version). J Hepatol 2003;38:533-540
25. Liaw YF, Leung N, Guan R, Lau GKK, Merican I. Asian-Pacific consensus statement on the management of chronic hepatitis B: an update. J Gastroenterol Hepatol 2003;18:239-245